HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Henyan, N. N. Articles by Coleman, C. I. Search for Related Content PubMed PubMed Citation Articles by Henyan, N. N. Articles by Coleman, C. I. Related Collections Cardiac - pharmacology

Ann Thorac Surg 2005;80:2402-2406
© 2005 The Society of Thoracic Surgeons

---

Review

Impact of Intravenous Magnesium on Post-Cardiothoracic Surgery Atrial Fibrillation and Length of Hospital Stay: A Meta-Analysis

^a Department of Pharmacy Practice, University of Connecticut, Hartford, Connecticut
^b Division of Drug Information, Hartford Hospital, Hartford, Connecticut
^c Division of Cardiology, Hartford Hospital, Hartford, Connecticut

^_* Address correspondence to Dr Coleman, University of Connecticut School of Pharmacy, Hartford Hospital, 80 Seymour St, CB 309, Hartford, CT 06102-5037 (Email: ccolema{at}harthosp.org).

Postoperative atrial fibrillation can occur in 25% to 40% of patients undergoing cardiothoracic surgery. Although the majority of postoperative atrial fibrillation is benign, it has been associated with prolonged hospital length of stay. Magnesium prophylaxis against postoperative atrial fibrillation has been evaluated in several clinical trials; however these trials were small in size and therefore conveyed mixed or inconclusive results. In an attempt to better understand magnesium's role in this setting, we conducted a meta-analysis. A systematic literature search was conducted from January 1999 through August 2004 to identify trials of prophylactic magnesium in the setting of cardiothoracic surgery. The primary outcome measure was the incidence of postoperative atrial fibrillation. Trials were further analyzed based on cumulative doses of magnesium and perioperative time of initiation of prophylaxis, as well as length of stay. Seven randomized trials were identified. Upon meta-analysis, magnesium was found to prevent postoperative atrial fibrillation with an odds ratio of 0.66 and 95% confidence interval of 0.51 to 0.87. The incidence of postoperative atrial fibrillation was also significantly reduced in the low dose with an odds ratio of 0.36 and 95% confidence interval of 0.23 to 0.56, and in the preoperative groups with an odds ratio of 0.46 and 95% confidence interval of 0.31 to 0.67. Prophylactic magnesium reduced length of stay (n = 6 studies) by a weighted mean difference of 0.29 days, with a 95% confidence interval 0.54 to 0.05. Prophylactic magnesium reduced cardiothoracic surgery patients' risk of postoperative atrial fibrillation and length of stay. Administering lower doses and initiating prophylaxis in the preoperative period achieved the greatest reduction in postoperative atrial fibrillation.

This article has been cited by other articles:

				M. E. Sleeswijk, J. E. Tulleken, T. Van Noord, J. H. J. M. Meertens, J. J. M. Ligtenberg, and J. G. Zijlstra Efficacy of magnesium-amiodarone step-up scheme in critically ill patients with new-onset atrial fibrillation: a prospective observational study. J Intensive Care Med, January 1, 2008; 23(1): 61 - 66. [Abstract] [PDF]

				R. E. Kettler, A. Parashar, M. I. Weintraub, A. Khoury, and M. Selim Perioperative Stroke N. Engl. J. Med., May 31, 2007; 356(22): 2325 - 2327. [Full Text] [PDF]

				W. L Baker and C M. White Post-Cardiothoracic Surgery Atrial Fibrillation: A Review of Preventive Strategies Ann. Pharmacother., April 1, 2007; 41(4): 587 - 598. [Abstract] [Full Text] [PDF]